These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18310838)

  • 1. Expression of truncated dystrophin cDNAs mediated by a lentiviral vector.
    Shunchang S; Haitao C; Weidong C; Jingbo H; Yunsheng P
    Neurol India; 2008; 56(1):52-6. PubMed ID: 18310838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vectors can be used for full-length dystrophin gene therapy.
    Counsell JR; Asgarian Z; Meng J; Ferrer V; Vink CA; Howe SJ; Waddington SN; Thrasher AJ; Muntoni F; Morgan JE; Danos O
    Sci Rep; 2017 Mar; 7(1):79. PubMed ID: 28250438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vectors can be used for full-length dystrophin gene therapy.
    Counsell JR; Asgarian Z; Meng J; Ferrer V; Vink CA; Howe SJ; Waddington SN; Thrasher AJ; Muntoni F; Morgan JE; Danos O
    Sci Rep; 2017 Mar; 7():44775. PubMed ID: 28303972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
    Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
    Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs.
    Yuasa K; Miyagoe Y; Yamamoto K; Nabeshima Y; Dickson G; Takeda S
    FEBS Lett; 1998 Mar; 425(2):329-36. PubMed ID: 9559674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional EGFP-dystrophin fusion proteins for gene therapy vector development.
    Chapdelaine P; Moisset PA; Campeau P; Asselin I; Vilquin JT; Tremblay JP
    Protein Eng; 2000 Sep; 13(9):611-5. PubMed ID: 11054455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
    Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP
    Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minidystrophin-EGFP fusion gene expressed in Cos-7 cells mediated by human source vector.
    Liang Y; Liang DS; Xue ZG; Long ZG; Wu LQ; Pan Q; Hu YQ; Dai HP; Xia K; Xia JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):493-6. PubMed ID: 16215933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duchenne muscular dystrophy treatment with lentiviral vector containing mini-dystrophin gene in vivo.
    Wang X; Zhu Y; Liu T; Zhou L; Fu Y; Zhao J; Li Y; Zheng Y; Yang X; Di X; Yang Y; He Z
    MedComm (2020); 2024 Jan; 5(1):e423. PubMed ID: 38188603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of lentiviral vector for truncated mouse fibroblast growth factor receptor-1 gene and its expression in eukaryotic cells].
    Chen W; Chen C; Zhang HX; Yan ZL; Cheng H; Zeng LY; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):168-72. PubMed ID: 22391190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction.
    Martone J; De Angelis FG; Bozzoni I
    Methods Mol Biol; 2012; 867():239-57. PubMed ID: 22454066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral delivery.
    Clemens PR; Krause TL; Chan S; Korb KE; Graham FL; Caskey CT
    Hum Gene Ther; 1995 Nov; 6(11):1477-85. PubMed ID: 8573620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant micro-genes and dystrophin viral vectors.
    Dickson G; Roberts ML; Wells DJ; Fabb SA
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S40-4. PubMed ID: 12206793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
    Koo T; Popplewell L; Athanasopoulos T; Dickson G
    Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts.
    Quenneville SP; Chapdelaine P; Rousseau J; Beaulieu J; Caron NJ; Skuk D; Mills P; Olivares EC; Calos MP; Tremblay JP
    Mol Ther; 2004 Oct; 10(4):679-87. PubMed ID: 15451452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
    Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
    J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transduction of recombinant marrow stem cells using lentiviral vector and adenoviral vector: a comparative study].
    Ma XS; Jiang JY; Lü FZ; Ma X; Li XK; Huang HY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3340-4. PubMed ID: 17313830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of large transgene cassettes by foamy virus vector.
    Sweeney NP; Meng J; Patterson H; Morgan JE; McClure M
    Sci Rep; 2017 Aug; 7(1):8085. PubMed ID: 28808269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.
    Phelps SF; Hauser MA; Cole NM; Rafael JA; Hinkle RT; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 1995 Aug; 4(8):1251-8. PubMed ID: 7581361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
    Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
    Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.